Novartis - Top 10 Layoffs of 2010

Company: Novartis
Layoffs: 1,400

Scoop: After much concern that Novartis would release Roche-esque layoffs, the company ended the year announcing 1,400 cuts from the sales department, all of which would be effective starting Jan. 1. The layoffs come primarily from the company's General Medicines sales force, as it prepares for the effects of numerous patent expirations. Instead, the company will focus its sales efforts on specialty drugs, according to a statement.

Novartis is still assessing its efficiency in sales, marketing and manufacturing, which could lead to more extensive job cuts in the coming years.

Novartis - Top 10 Layoffs of 2010

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.